Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.64
Price to sales ratio
1.22

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3377
TKNO
Alpha Teknova, Inc. - Common Stock
5.41 USD+0.93%-2.35%+28.81%+21.30%290.05 M USD
3454
SIGA
SIGA Technologies Inc. - Common Stock
3.61 USD+0.56%-4.50%-16.82%-57.53%258.92 M USD
3666
DERM
Journey Medical Corporation - Common Stock
6.86 USD-0.72%-5.90%+7.69%-7.30%188.89 M USD
3717
LFCR
Lifecore Biomedical, Inc. - Common Stock
4.63 USD-2.53%-7.95%-18.20%-43.26%173.67 M USD

Frequently asked questions about Anika Therapeutics Inc. - Common Stock

What is the Anika Therapeutics Inc. - Common Stock stock price today?

The current price of Anika Therapeutics Inc. - Common Stock (ANIK) is 15.77. Over the past 24 hours, the stock has changed by +1.09%. Follow the ANIK chart for real-time price dynamics.

What is the stock ticker of Anika Therapeutics Inc. - Common Stock?

Anika Therapeutics Inc. - Common Stock trades under the ticker ANIK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Anika Therapeutics Inc. - Common Stock stock going up?

ANIK has changed by -2.59% over the last week, +7.13% over the last month, and +55.52% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Anika Therapeutics Inc. - Common Stock net income for the last quarter?

Anika Therapeutics Inc. - Common Stock reported net income of -5.06 M for the last quarter. The previous quarter showed 292 K, which means net income changed by -1831.51%.

How many employees does Anika Therapeutics Inc. - Common Stock have?

As of the latest available data, Anika Therapeutics Inc. - Common Stock has 235 employees. Workforce size can provide additional context about the company's scale and operations.

What is Anika Therapeutics Inc. - Common Stock EBITDA?

Anika Therapeutics Inc. - Common Stock EBITDA is 6.53 M, and its EBITDA margin is 22.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Anika Therapeutics Inc. - Common Stock stock?

You can buy Anika Therapeutics Inc. - Common Stock (ANIK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Anika Therapeutics Inc. - Common Stock stock?

Investing in Anika Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANIK chart and related analysis on metatrader.com as part of your research.

News